The Impact of Plant-Based Protein-rich Food Products With Varying Degree of Processing on the Human Gut Microbiome Composition and Human Metabolome

NCT ID: NCT05885750

Last Updated: 2023-06-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-05

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is observed that replacing meat with protein-rich plant-based food products are associated with lower mortality and obesity prevention. Sources of plant proteins typically undergo several processing and refinement procedures to improve the taste and digestibility of plant-based food products. These procedures alter the chemical composition, which can impact the nutritional quality of the processed food. It is not known what is the impact of processed products on human metabolism and intestinal microbiota. Therefore, the impact of a set of plant-based protein-rich food products with varying degree of processing on the composition and function of human gut microbiome and metabolism will be assessed in a clinical intervention

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Plant-based diets are known to have beneficial effects on both the environment and human health. Replacing animal protein with plant protein reduces overall mortality risk, and replacing meat with legumes and other sources of plant protein can lower the risk of chronic diseases such as type 2 diabetes and cardiovascular disease. However, the benefits of plant protein products is not evident. In order to make plant protein products more palatable and digestible, plant raw materials may go through several processing and refinement procedures. Typically, during these phases, carbohydrate fractions (e.g. dietary fiber) are removed from the plant material, which results in the loss of micronutrients as well as secondary plant metabolites with potentially health effects (e.g. polyphenolic compounds). Salt and various fats are added to some products, which can reduce the nutritional quality of the product. Subsequently, not all plant-based protein-rich foods are automatically healthy as there may be significant differences in the nutritional quality of the processed products, depending on the food processing utilized. Only little research information is available on the effects of processed plant protein products on human metabolism and intestinal microbiota. Therefore, this cross-over clinical intervention will be conducted with 38 healthy participants to investigate the impact of a set of plant-based protein-rich food products with varying degree of processing on the composition and function of human gut microbiome and metabolism will be assessed in a clinical intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolism Gut Microbiota Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Crossover trial with two one-week wash-out periods in-between three interventions
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diet 1

Unprocessed or minimally processed plant-based protein-rich food products

Group Type EXPERIMENTAL

Unprocessed

Intervention Type BEHAVIORAL

Participants will consume unprocessed or minimally processed commercially available plant-based protein-rich foods as meat replacement in their normal diet for one week.

Diet 2

Mildly processed plant-based protein-rich food products

Group Type EXPERIMENTAL

Mildly processed

Intervention Type BEHAVIORAL

Participants will consume mildly processed commercially available plant-based protein-rich foods as meat replacement in their normal diet for one week.

Diet 3

Heavily refined plant-based protein-rich food products

Group Type EXPERIMENTAL

Heavily refined

Intervention Type BEHAVIORAL

Participants will consume heavily refined processed commercially available plant-based protein-rich foods as meat replacement in their normal diet for one week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Unprocessed

Participants will consume unprocessed or minimally processed commercially available plant-based protein-rich foods as meat replacement in their normal diet for one week.

Intervention Type BEHAVIORAL

Mildly processed

Participants will consume mildly processed commercially available plant-based protein-rich foods as meat replacement in their normal diet for one week.

Intervention Type BEHAVIORAL

Heavily refined

Participants will consume heavily refined processed commercially available plant-based protein-rich foods as meat replacement in their normal diet for one week.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willingness to participate
* 18-65-years olf
* BMI 18.5-27 kg/m2

Exclusion Criteria

* Chronic disease with continuous medication
* Antibiotic use in the past 6 months
* Active smoker
* Gluten-free or vegan diet
* Pregnancy, lactation
* Abnormal thyroid, liver, or kidney function
* Low hemoglobin
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Turku

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marko Kalliomäki, MD

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kati Hanhineva, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Turku

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Food Sciences Unit, Department of Life Technologies, Faculty of Technology, University of Turku

Turku, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Veera Houttu, PhD

Role: CONTACT

+358504627287

Kaisa Linderborg, PhD

Role: CONTACT

+358294502472 ext. +358504395535

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kati Hanhineva, PhD

Role: primary

+358294504044

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Newplant

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Vegan Diet on Microbiome and Metabolism
NCT07003230 NOT_YET_RECRUITING NA
Diet and Health in Adults With Metabolic Syndrome
NCT03935048 ACTIVE_NOT_RECRUITING NA